Senators oppose use of Dengvaxia vaccine

Senators oppose use of Dengvaxia vaccine

Some senators are voicing up their apprehensions regarding the call to reevaluate the use of the controversial Dengvaxia vaccine.

For one Senate President Vicente Sotto III said questions regarding the efficacy of Dengvaxia-  manufactured by Sanofi Pasteur and tested in the country remains to unresolved.

Sotto, call s for patience and the government should wait the recommendations on the controversial vaccine before considering the use of the product.

(photo credit to owner)

“If it was not effective before, how can it be effective now?” Sotto said. “It’s not that I’m not amenable, we all want protection from or cure for dengue, but there is uncertainty in the product.”

The chairman of Blue Ribbon Committee, Sen. Richard Gordon that investigated the Dengvaxia controversy in the last Congress (17th), said releasing the vaccine to the market for use would be a “catastrophic step in the wrong direction.”

Gordon said when the Blue Ribbon committee probed the P3.5-billion procurement of the vaccines in 2016, the senators found “a lot of ethical things happening,” including meetings between then president Benigno Aquino III and former health secretary Janet Garin with Sanofi-Pasteur executives.

Gordon also revealed that he wrote a letter to Department of Health(DOH) Secretary Francisco Duque III two weeks ago requesting him to check on whether those inoculated with the vaccine got sick again with dengue.

Share us your thoughts by simply leaving on the comment section below. For more news updates, feel free to visit our site often.

Stay updated with today's relevant news and trends by hitting the LIKE button.

Thanks for dropping by and reading this post.

Report from PhiStar

Post a Comment